Drug intelligence / Profile preview

low-molecular-weight fucoidan

Development stage
Unknown
Lead developer
Hi-Q Marine Biotech International
Modality
Small Molecules
Administration
Oral
01

Overview

Low-molecular-weight fucoidan (LMWF) is a sulfated polysaccharide derived from brown seaweed, characterized by a lower molecular weight than natural fucoidan, which enhances its bioavailability and biological activity. It exhibits multiple biological activities, including anti-inflammatory, anti-oxidative, and anti-thrombotic properties. In the context of diabetic cardiovascular complications, LMWF has been shown to protect vasoendothelial function by preserving endothelial nitric oxide synthase (eNOS) activity, specifically by promoting eNOS phosphorylation at Ser1177 and increasing nitric oxide (NO) production. This mechanism helps ameliorate hypertension and endothelial dysfunction in type 2 diabetes models. It is also being investigated as an adjuvant in oncology to improve the efficacy of chemotherapy and mitigate its side effects.

Brand names
Oligo-Fucoidan
Other names
low molecular weight fucoidandepolymerized fucoidan
02

Targets

SDC4 (Syndecan-4)HPSE (Heparanase)

Beyond the preview

Go deeper on low-molecular-weight fucoidan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on low-molecular-weight fucoidan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call